BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 768906)

  • 41. Acebutolol in hypertension--double-blind trial against placebo.
    Martin MA; Phillips CA; Smith AJ
    Br J Clin Pharmacol; 1978 Oct; 6(4):351-6. PubMed ID: 359018
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Circulatory effects of intravenous and oral acebutolol in acute myocardial infarction.
    Silke B; Nelson G; Verma SP; Clarke J; Baliga G; Taylor SH
    Clin Pharmacol Ther; 1985 Sep; 38(3):266-72. PubMed ID: 4028620
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acebutolol-induced decrease of mononuclear leukocyte beta-adrenoceptors in hypertension.
    Basso A; Piantanelli L; Cognini G; Giunta S; Andreoni A; Paciaroni E
    Pharmacology; 1985; 31(5):278-83. PubMed ID: 2999840
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clonidine, acebutolol and their interaction in essential hypertension: effects on blood pressure and the control of water and electrolyte balance.
    Plouin PF; Degoulet P; Fermé I; Cornette M; Ménard J
    Eur Heart J; 1983 Nov; 4 Suppl G():7-11. PubMed ID: 6363082
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of age on the hemodynamic response to posture in nonelderly hypertensive patients.
    Fagard R; Lijnen P; Staessen J; Thijs L; Amery A
    Am J Hypertens; 1994 Jan; 7(1):30-5. PubMed ID: 8136108
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effects of acebutolol alone and in combination with furosemide or hydralazine in experimentally induced hypertensive G-minipigs.
    Yasuda Y; Hidaka H; Sawada S; Tanioka Y
    Jikken Dobutsu; 1986 Oct; 35(4):367-73. PubMed ID: 3542535
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Haemodynamic effects of beta blockade in hypertrophic cardiomyopathy using Sectral (acebutolol; M and B 17803A).
    Lewis BS; Mitha AS; Bakst A; Purdon K; Gotsman MS
    Cardiovasc Res; 1974 Mar; 8(2):249-62. PubMed ID: 4150819
    [No Abstract]   [Full Text] [Related]  

  • 48. Acute and long-term effects of acebutolol on systemic and renal hemodynamics, body fluid volumes, catecholamines, active renin, aldosterone, and lymphocyte beta-adrenoceptor density.
    van den Meiracker AH; Man in 't Veld AJ; Fischberg DJ; Molinoff PB; van Eck HJ; Boomsma F; Derkx FH; Schalekamp MA
    J Cardiovasc Pharmacol; 1988 Apr; 11(4):413-23. PubMed ID: 2453744
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Electrophysiological properties of injectable acebutolol. A study of one case of auriculo-ventricular block observed under acebutolol per os (author's transl)].
    Clementy J; Clementy A; Roudaut R; Dallocchio D; Levy S; Bricaud H
    Ann Cardiol Angeiol (Paris); 1979; 28(4):261-8. PubMed ID: 507735
    [No Abstract]   [Full Text] [Related]  

  • 50. Systemic haemodynamic effects of biofeedback in borderline hypertension.
    Messerli FH; Decarvalho JG; Christie B; Frohlich ED
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():437s-439s. PubMed ID: 396087
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acebutolol in hypertension: relationships between drug concentration and effects.
    Martin MA; Phillips FC; Tucker GT; Smith AJ
    Eur J Clin Pharmacol; 1978 Dec; 14(6):383-90. PubMed ID: 367793
    [No Abstract]   [Full Text] [Related]  

  • 52. Cardiovascular and endocrine effects of acupuncture in hypertensive patients.
    Chiu YJ; Chi A; Reid IA
    Clin Exp Hypertens; 1997 Oct; 19(7):1047-63. PubMed ID: 9310203
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of acebutolol on the cerebral circulation of man.
    Hares P; James IM; Griffith D
    Br J Clin Pharmacol; 1977 Jun; 4(3):373-5. PubMed ID: 901707
    [No Abstract]   [Full Text] [Related]  

  • 54. Effects of acute and chronic administration of acebutolol on the right ventricular effective refractory period in conscious dogs.
    Vincent A; Werquin S; Caron J; Libersa C; Fautrez V; Dupuis B
    J Cardiovasc Pharmacol; 1993 Jan; 21(1):7-12. PubMed ID: 7678681
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Suppression of ventricular arrhythmia by acebutolol.
    Santoso T; Nursyirwan EF; Trisnohadi HB; Manurung D; Rahman AM; Abdurahman N
    Clin Cardiol; 1983 Feb; 6(2):58-63. PubMed ID: 6831786
    [No Abstract]   [Full Text] [Related]  

  • 56. Large-scale in silico identification of drugs exerting sex-specific effects in the heart.
    Cui C; Huang C; Liu K; Xu G; Yang J; Zhou Y; Feng Y; Kararigas G; Geng B; Cui Q
    J Transl Med; 2018 Aug; 16(1):236. PubMed ID: 30157868
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Electrophysiological effects of acebutolol.
    Mason JW; Winkle RA; Meffin PJ; Harrison DC
    Br Heart J; 1978 Jan; 40(1):35-40. PubMed ID: 341930
    [No Abstract]   [Full Text] [Related]  

  • 58. Spontaneous oscillation of the systemic arterial pressure during cardiopulmonary bypass in man. The effects of some drugs used during the operation.
    Vainionpää V; Timisjärvi J
    Basic Res Cardiol; 1987; 82(2):178-85. PubMed ID: 2886117
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adrenergic receptors and renin release.
    Wilton A; Joshi PI
    Lancet; 1977 Mar; 1(8013):698-9. PubMed ID: 66491
    [No Abstract]   [Full Text] [Related]  

  • 60. Haemodynamic effects of acebutolol.
    Mason JW; Specter MJ; Ingels NB; Daughters GT; Ferris AC; Alderman EL
    Br Heart J; 1978 Jan; 40(1):29-34. PubMed ID: 341929
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.